Neurocrine Biosciences
NBIX
#1602
Rank
NZ$23.26 B
Marketcap
NZ$233.32
Share price
-1.04%
Change (1 day)
-9.22%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company